XOMA (US) LLC (XOMA) Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients 2/9/2010
More...
|
Novo Nordisk A/S (NVO)'s Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes 1/27/2010
More...
|
Novo Nordisk A/S (NVO) Gets Regulatory Approval for Victoza in Japan 1/20/2010
More...
|
Pedometer Could Cut Type 2 Diabetes Risk By Half, University of Leicester Study 1/4/2010
More...
|
Roche (RHHBY) (JOBS), Ipsen (JOBS) Diabetes Drug Meets Goals in Studies 12/17/2009
More...
|
Array BioPharma, Inc. (ARRY) and Amgen (AMGN) (JOBS) Partner in Type 2 Diabetes; Amgen to Pay $60 Million Up-front with Additional Potential Milestones and Royalties 12/15/2009
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Reports Positive Data from Byetta Study 12/15/2009
More...
|
Novo Nordisk A/S (NVO) Starts Phase 1 Trial With Oral Insulin Analogue -- Merrion Pharmaceuticals, Inc. Earns USD 2 Million Milestone Payment 12/7/2009
More...
|
Spherix (SPEX) Says Diabetes Drug Shows Promise; Shares Jump 11/16/2009
More...
|
Eli Lilly and Company (LLY): Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease 11/16/2009
More...
|
Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 11/13/2009
More...
|
US FDA Issues Alert on Kidney Problems with Eli Lilly and Company (LLY) (JOBS), Amylin Pharmaceuticals, Inc. (AMLN)'s (JOBS) Byetta 11/3/2009
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) (JOBS) Says Byetta Gets FDA Approval for New Use 11/2/2009
More...
|
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical(TM) Therapy 11/2/2009
More...
|
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic Therapy 11/2/2009
More...
|
GI Dynamics' EndoBarrier(TM) Gastrointestinal Liner Demonstrates Safety and Efficacy in Pre-surgical Weight Loss 10/27/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Buys Wellstat Therapeutics Corporation's Type II Diabetes Drug PN2034 For Up To $350 Million 10/21/2009
More...
|
Tolerx, Inc. Presents Otelixizumab Phase 2 Dose Optimization Data At The IDF's 20th World Diabetes Congress 10/21/2009
More...
|
XOMA (US) LLC (XOMA) Announces Initiation of Its Phase 2 Clinical Program for XOMA 052 in Type 2 Diabetes and Cardiovascular Disease 10/1/2009
More...
|
Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 9/17/2009
More...
|
Lexicon Pharmaceuticals, Inc. (LXRX) Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 9/16/2009
More...
|
SynCo Bio Partners B.V. to Manufacture Versartis, Inc.'s Novel Drug for Type 2 Diabetes 8/17/2009
More...
|
XOMA (US) LLC (XOMA) Announces Positive Results From U.S. Phase 1 Trial of XOMA 052 in Type 2 Diabetes 7/15/2009
More...
|
Peer-Reviewed Publications Demonstrate Tethys Bioscience, Inc.'s Ability to Identify Those at Highest Risk of Developing Type 2 Diabetes Within Five Years 7/15/2009
More...
|
DARA BioSciences, Inc. Releases Promising Preclinical Type 2 Diabetes Data for First-in-Class DB959 7/14/2009
More...
|
XOMA (US) LLC (XOMA) Announces Conference Call and Webcast On July 14 to Review Top Line Multi-dose and Other Results of Its Phase 1 Clinical Trial of XOMA 052 in Type 2 Diabetes 7/7/2009
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Fails to Get U.S. Approval for Diabetes Drug 6/30/2009
More...
|
Gene Inhibition May Help Normalize Type 2 Diabetes, Yale University School Of Medicine Study 6/19/2009
More...
|
XOMA (US) LLC (XOMA) Release: XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment 6/8/2009
More...
|
CombinatoRx, Incorporated (CRXX)'s Diabetes Drug Meets Trial Goal, Shares Up 5/28/2009
More...
|
Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 5/27/2009
More...
|
FDA Approves Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s ACTOplus met(R) XR Tablets for the Treatment of Type 2 Diabetes 5/14/2009
More...
|
Novo Nordisk A/S (NVO)'s Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study 5/8/2009
More...
|
VeroScience Announces FDA Approval of Cycloset for Treatment of Type 2 Diabetes 5/6/2009
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule 5/5/2009
More...
|
Novo Nordisk A/S (NVO) Tumor Data Concern for Humans 4/3/2009
More...
|
Bristol-Myers Squibb Company (BMY), AstraZeneca PLC (AZN) ONGLYZA (saxagliptin) Cardiovascular Profile Acceptable According to FDA Advisory Committee; Rival to Merck & Co., Inc. (MRK)'s Januvia Moves Closer to Approval 4/2/2009
More...
|
Altea Therapeutics Announces Development and Commercialization Agreement with Amylin Pharmaceuticals, Inc. (AMLN) and Eli Lilly and Company (LLY) for an Investigational Transdermal Exenatide 4/1/2009
More...
|
University of Minnesota Study Shows Potential For Resolving Type 2 Diabetes With Bariatric Surgery 3/3/2009
More...
|
DiaMedica Inc. Announces Last Patient Out for DM-99 Phase IIa Human Clinical Trial 2/10/2009
More...
|
DiaKine Therapeutics, Inc. Drug Improves Type 2 Insulin Action; Reduces Harm of Fat in Preclinical Study 1/22/2009
More...
|
Saliva Test Could Monitor Type 2 Diabetes, Nizam's Institute of Medical Sciences University Study 1/21/2009
More...
|
DiaMedica Inc. Cleared to Initiate Its Second Phase II Clinical Trial of DM-71 in Patients With Type 2 Diabetes 1/15/2009
More...
|
MannKind Corporation (MNKD) to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 12/16/2008
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate 12/15/2008
More...
|
VIVUS, Inc. (VVUS) Release: Qnexa Reduces Hemoglobin A1c By 1.6% in 56 Weeks 12/12/2008
More...
|
Merck & Co., Inc. (MRK) Release: New Study Data: JANUVIA(TM) (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 11/21/2008
More...
|
Elixir Pharmaceuticals' Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates Significant Reductions in HbA1c (Blood Glucose) Levels Compared to Type 2 Diabetes Patients Not Well-Controlled on Metformin Alone 11/19/2008
More...
|
Biodel Inc. (BIOD) Reports Protective Effects of VIAject(TM) Insulin on Microvascular Function in Patients with Type 2 Diabetes 11/17/2008
More...
|
Japan's Ministry of Health Release: Type 2 Diabetics Studied in Low-Dose Aspirin Trial 11/11/2008
More...
|
Generex Biotechnology Corporation (GNBT) Comments On New ADA/EASD Consensus Algorithm for Type 2 Diabetes Treatment 10/30/2008
More...
|
Novo Nordisk A/S (NVO) New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes 10/17/2008
More...
|
Generex Biotechnology Corporation (GNBT) Announces Enrollment of Initial Subjects in Metformin Gum Trial 10/16/2008
More...
|
Biodel Inc. (BIOD) Announces Timing of FDA Discussions on VIAject(TM) New Drug Application 10/10/2008
More...
|
FDA Will Not Be Able To Complete Its Review Of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s (JOBS) Alogliptin (SYR-322) NDA By The Prescription Drug User Fee Act (PDUFA) Date Of October 27, 2008; Delay Puts PPD, Inc. (PPDI) Payment On Hold 10/10/2008
More...
|
Analogue Or Human Insulins OK For Type 2 Diabetes, John Hopkins Hospital Study 10/2/2008
More...
|
ZenBio, Inc. Awarded $1.38 Million Phase II SBIR Grant for Skeletal Muscle Program 9/30/2008
More...
|
Bay Area DNA Decoding Company, 23andMe, Inc. Gets More Personal 9/26/2008
More...
|
Continuous Glucose Monitoring In Diabetic Pregnant Women Lowers Risk Of Complications, Ipswich Hospital Study 9/26/2008
More...
|
Array BioPharma, Inc. (ARRY) Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 Diabetes 9/25/2008
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 9/24/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Initiation of a Clinical Trial for MB07803, Its Novel Product Candidate for the Treatment of Type 2 Diabetes 9/24/2008
More...
|
GI Dynamics' New Noninvasive Device Could Control Diabetes, Harvard Medical School and Massachusetts General Hospital Study 9/18/2008
More...
|
Insulin Mixes May Work Better Than Longer-Lasting Medicines, Johns Hopkins University School of Medicine Study 9/18/2008
More...
|
Key Protein Molecule Linked To Diverse Human Chronic Inflammatory Diseases, Virginia Tech Study 9/17/2008
More...
|
Gastric Stimulator Induces Weight Loss In Diabetics, Hopital Jeanne-d'Arc 9/16/2008
More...
|
GI Dynamics Announces Data Demonstrating Immediate and Sustained Reduction in HbA1c in Patients with Type 2 Diabetes Using EndoBarrier™ Gastrointestinal Liner 9/16/2008
More...
|
Acurian, Inc. Announces Direct Access to Over 50% of Diagnosed Type 2 Diabetics for the Purpose of Clinical Trial Recruitment 9/15/2008
More...
|
Transition Therapeutics Inc. (TTH.TO) Dose First Patient in Phase 2 Clinical Study of TT-223 in Type 2 Diabetes 9/12/2008
More...
|
University of Oxford Study Sees Longterm Benefit Of Blood-Sugar Control 9/10/2008
More...
|
GI Dynamics Release: Data from Clinical Trial of EndoBarrier(TM) Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York City 9/9/2008
More...
|
Merck & Co., Inc. (MRK) Release: Five New Studies at Major Medical Meeting Further Demonstrate Clinical Experience for JANUVIA(TM) (sitagliptin) 9/9/2008
More...
|
Weekly Diabetes Drug Exenatide Provides Better Blood Sugar Control, Spurs Weight Loss, Mount Sinai Hospital Study 9/8/2008
More...
|
Novo Nordisk A/S (NVO) New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 9/8/2008
More...
|
XOMA (US) LLC (XOMA) 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Targeting Inflammatory Damage to Insulin-Producing Cells 9/8/2008
More...
|
Class Of Diabetes Drugs Carries Significant Cardiovascular Risks, Wake Forest University School of Medicine Study 8/29/2008
More...
|
Classen Immunotherapies Inc. More Evidence Published That Epidemics of Childhood Obesity, Type 2 Diabetes and Metabolic Syndrome are Linked to Immunization 8/26/2008
More...
|
ActivX Biosciences, Inc. Announces Positive Phase Ib and IIa Clinical Trial Results for KRP-104, a Flexible Dosing DPP-4 Inhibitor for Type 2 Diabetes 8/21/2008
More...
|
Levels Of C-reactive Protein In The Blood Do Not Cause Diabetes, Royal Free and University College Medical School Study 8/13/2008
More...
|
Pfizer Inc. (PFE) Release: Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease 8/7/2008
More...
|
AtheroGenics (AGIX) Diabetes Drug Trial Meets Main Goal 7/31/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX)' Results from Its Phase 2a Clinical Trial for MB07803 to Be Presented at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 7/30/2008
More...
|
Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 7/29/2008
More...
|
Some Sweeteners Inhibit Enzyme Tied to Type 2 Diabetes, Journal of Medicinal Food 7/28/2008
More...
|
Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN) Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) for the Treatment of Type 2 Diabetes 7/23/2008
More...
|
Merck & Co., Inc. (MRK)'s JANUMET (TM) Approved in the European Union for Treatment of Type 2 Diabetes
7/22/2008
More...
|
Sanofi-Aventis (France) (SASY.PA) Release: Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 7/22/2008
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Commences Phase II Clinical Trial with TRIOLEX™ (HE3286) in Type-2 Diabetes Patients; Expands Sites to Accelerate Enrollment 7/16/2008
More...
|
American Diabetes Association Urges Congress to Examine Ravages of Childhood Obesity and Type 2 Diabetes 7/16/2008
More...
|
FDA (JOBS) Updates Label for GlaxoSmithKline (GSK)'s (JOBS) AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 7/14/2008
More...
|
DiaMedica Inc. Meets Primary Endpoint from Phase II DM-83 Study in Type 2 Diabetes 7/14/2008
More...
|
Genaera Corporation (GENR) Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting 7/14/2008
More...
|
VIVUS, Inc. (VVUS) Announces New Data from Qnexa Diabetes Study 6/26/2008
More...
|
Johns Hopkins University Study Finds Depression Can Trigger Diabetes 6/18/2008
More...
|
Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/17/2008
More...
|
Center for Inherited Disease Research Adds Affymetrix (Santa Clara, California) (AFFX) Platform for Large-Scale Genotyping Services 6/16/2008
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Weekly Diabetes Drug Lowers Blood Sugar 6/10/2008
More...
|
Amylin Pharmaceuticals, Inc. (AMLN), Novo Nordisk, Inc. (NVO) Battle for Diabetes Market 6/10/2008
More...
|
Incyte Corporation (INCY)'s Selective Oral Inhibitor of 11beta-HSD1 Demonstrates Improvements in Insulin Sensitivity and Lowers Cholesterol Levels in Type 2 Diabetics 6/10/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX) Presents Preclinical Results for MB07803, Its Product Candidate for Type 2 Diabetes, and Its Glucagon Antagonist Program at the American Diabetes Association Meeting 6/10/2008
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin Results from a 24-week multi-center, randomized, open-label study presented at American Diabetes Association 2008 6/10/2008
More...
|
Novo Nordisk A/S (NVO) New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 6/10/2008
More...
|
Intensive Control Of Blood Sugar Does Not Reduce Heart Risk In Type 2 Diabetes, National Institutes of Health (NIH) and George Institute for International Health Study Finds 6/9/2008
More...
|
University of Southern California Scientists ID Gene Regulating Blood Glucose Levels 6/9/2008
More...
|
Abbott Laboratories (ABT)'s Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes 6/9/2008
More...
|
Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN)'s ONGLYZA(TM) Demonstrated Significant Reductions in Key Measures of Glucose Control in Treatment Naive People with Type 2 Diabetes 6/9/2008
More...
|
Novo Nordisk A/S (NVO) Release: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients With Type 2 Diabetes 6/9/2008
More...
|
Takeda Global Research & Development Release: Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-On Therapy Studies 6/9/2008
More...
|
Sanofi-Aventis (France) (SASY.PA) Diabetes Drug Shows Promise in Study 6/9/2008
More...
|
XOMA (US) LLC (XOMA) 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At American Diabetes Association 6/9/2008
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Reports Additional Positive Data from Phase I/II Clinical Trial with TRIOLEX(TM) Supporting Anti-Inflammatory Approach to Treating Type 2 Diabetes 6/9/2008
More...
|
Merck & Co., Inc. (MRK) Release: A New Analysis Released at American Diabetes Association: Lower Risk of Symptomatic Hypoglycemia with JANUVIA(TM) (sitagliptin) Compared to Glipizide on a Background of Metformin in Patients with Type 2 Diabetes 6/9/2008
More...
|
KineMed, Inc. New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes 6/9/2008
More...
|
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting 6/9/2008
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) and Eli Lilly and Company (LLY) Monotherapy BYETTA(R) Injection Study Results Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 6/9/2008
More...
|
KineMed, Inc. and Daiichi Sankyo Co Ltd. Release: New Discovery of Key Difference in Bile Acid Metabolism in Patients With Type 2 Diabetes May Suggest Underlying Disorder 6/9/2008
More...
|
Novo Nordisk A/S (NVO) Release: New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) Is as Effective as Glargine Over a 24-Hour Period in Subjects With Type 2 Diabetes 6/9/2008
More...
|
American Diabetes Association Release: Intense Blood Glucose Control Yields No Significant Effect on CVD Reduction in VA Diabetes Trial 6/9/2008
More...
|
American Diabetes Association Release: Periodontitis Associated With Development of Type 2 Diabetes and Its Complications 6/9/2008
More...
|
Two-Drug Combo Reduces Diabetic Kidney Damage; Almost 25 Percent Of Participants Saw Urine Protein Levels Lowered Significantly, Study Published In New England Journal of Medicine 6/5/2008
More...
|
Akesis Pharmaceuticals Completes Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/4/2008
More...
|
Protein Fibrils As Alternative Plastics? Amyloids Are Not Just Pathological Agents, They Are Interesting Nanomaterials, University of Tel Aviv Researchers Find 5/29/2008
More...
|
Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator 5/28/2008
More...
|
Metabolic Syndrome Can't Predict Heart Risk, University of Glasgow Study 5/22/2008
More...
|
Phenomix Corporation Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes 5/19/2008
More...
|
Daiichi Sankyo Co Ltd. Release: Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes 5/16/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Positive Results in the Phase 2a Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes 4/28/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX) Announces Extension of Its Collaboration with Merck & Co., Inc. (MRK) to Develop AMPK Activators for Diabetes and Other Metabolic Diseases 4/23/2008
More...
|
Sirtris Pharmaceuticals (SIRT) Announces SRT501 Lowers Glucose in Twice-Daily Dosing Clinical Trial; Study Suggests Dose Response for Proprietary Formulation of Resveratrol in Type 2 Diabetics 4/17/2008
More...
|
Daiichi Sankyo Co Ltd. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists 'Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus' 4/15/2008
More...
|
AtheroGenics (AGIX) Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes 4/14/2008
More...
|
Classen Immunotherapies Inc. Release: Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic Syndrome Japanese and Other Ethnic Minorities at Increased Risk 4/4/2008
More...
|
DiObex, Inc. Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics 4/1/2008
More...
|
Six New Genes Associated With Type 2 Diabetes Discovered, Including One With Role In Prostate Cancer 3/31/2008
More...
|
Takeda Global Research & Development Release: New Data Showed ACTOS(R) (Pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes 3/31/2008
More...
|
Once-Daily Insulin Shot Proves Effective in Study 3/28/2008
More...
|
Two Cholesterol Drugs Better Than One For Diabetics, American Journal of Cardiology 3/25/2008
More...
|
Metabolex, Inc. Initiates Phase 1 Trial of MBX-2982 3/25/2008
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Approval to Conduct Phase 2A Trials of Its Oral Insulin Capsule 3/18/2008
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Reports Positive Preliminary Data from Ongoing Phase I/II Clinical Trial with TRIOLEX(TM) in Obese Insulin Resistant Subjects 3/18/2008
More...
|
Akesis Pharmaceuticals Provides Preliminary Data from Phase IIa Trial of AKP-020 for Type 2 Diabetes 3/17/2008
More...
|
Low Levels Of PYY Hormone A Very Early Indicator Of Type 2 Diabetes, Garvan Institute of Medical Research Study 3/11/2008
More...
|
Arisaph Pharmaceuticals, Inc. Announces FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 3/11/2008
More...
|
DiaMedica Inc. Receives Regulatory Clearance for Phase II Human Study of DM-99 3/4/2008
More...
|
Metabasis Therapeutics, Inc. (MBRX) Completes Enrollment of Its Proof-of-Concept Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes 2/28/2008
More...
|
InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2/25/2008
More...
|
Akesis Pharmaceuticals Doses First Patient in Phase IIa Trial of AKP-020 for Type 2 Diabetes 2/25/2008
More...
|
Elixir Pharmaceuticals Presents New Data on Ghrelin Inhibition at Keystone Meeting 2/22/2008
More...
|
Phase III Program for AVE0010/ZP10 Licensed From Sanofi-Aventis (France) (SASY.PA) will Begin in the First Quarter of 2008 2/12/2008
More...
|
Bentley Pharmaceuticals (BNT) Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results 2/11/2008
More...
|
Eli Lilly and Company (LLY) Announces Discontinuation of Humatin (Paromomycin Sulfate Capsules, USP) 2/8/2008
More...
|
Avandia Not Linked To Increased Risk In Study Says GlaxoSmithKline (GSK) 2/6/2008
More...
|
7TM Pharma Announces Selection of a New Pre-clinical Development Candidate 2/6/2008
More...
|
Sirtris Pharmaceuticals (SIRT): Novel, Potent SIRT1 Activator Reduces Fat, Boosts Endurance and Improves Insulin Sensitivity in a Pre-clinical Model of Type 2 Diabetes 1/24/2008
More...
|
Genaera Corporation (GENR) Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) 1/24/2008
More...
|
Biovail Corporation (BVF) Announces Canadian Commercial Availability of 1,000mg Dosage of Glumetza(TM) 1/24/2008
More...
|
Diabetes Study Favors Surgery to Treat Obese 1/23/2008
More...
|
Daiichi Sankyo, Inc.'s Welchol(TM) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 1/21/2008
More...
|
Merck Sharp & Dohme (MRK) Release: Expanded Labelling for Januvia Approved by European Commission 1/21/2008
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes 1/8/2008
More...
|
Sirtris Pharmaceuticals (SIRT) Announces Positive Results with Proprietary Version of Resveratrol, SRT501, in a Phase 1b Type 2 Diabetes Clinical Study 1/8/2008
More...
|
Takeda Global Research & Development Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 1/4/2008
More...
|
Biodel Inc. (BIOD) Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM) 1/4/2008
More...
|
Ambrx, Inc. Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck & Co., Inc. (MRK) 12/18/2007
More...
|
AtheroGenics (AGIX) Completes Enrollment in ANDES Phase III Clinical Trial of AGI-1067 12/18/2007
More...
|
DiaMedica Inc. Receives Regulatory Clearance for Phase II Human Study of DM-83 12/13/2007
More...
|
Sirtris Pharmaceuticals (SIRT)' SIRT1 Activator Controls Glucose as well as a DPP-4 inhibitor in a Pre-Clinical Model of Type 2 Diabetes 12/13/2007
More...
|
Vanderbilt University Will Help Test Device to Ease Diabetes 12/10/2007
More...
|
Dia-B Tech Ltd. (DA1.BE) Happy with Phase 2 Diabetes Drug 12/6/2007
More...
|
DiaMedica Inc.: DM-83 Restores Meal Associated Insulin Sensitivity in Pre-clinical Study 12/6/2007
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) and Eli Lilly and Company (LLY) Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 12/6/2007
More...
|
MetaCure Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight 11/28/2007
More...
|
Sirtris Pharmaceuticals (SIRT) and Harvard University Unveil Promising, Novel SIRT1 Activators for Treating Diseases of Aging; Therapeutic Type 2 Diabetes Data Published in the Journal Nature 11/28/2007
More...
|
Mercury Therapeutics, Inc. Breakthrough for Patients With Type-2 Diabetes 11/26/2007
More...
|
Novo Nordisk, Inc. (NVO) Announces Exclusive Agreement With Sciele Pharma, Inc. (SCRX) to Market Prandin(R) 11/19/2007
More...
|
FDA Accepts Akesis Pharmaceuticals' AKP-020 IND Application for a Phase IIa Study in the Treatment of Type 2 Diabetes 11/12/2007
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Says New Diabetes Injection Meets Main Goal 10/31/2007
More...
|
Forbes Medi-Tech Inc. (FMTI) Enters Final Steps in Compound Selection for Asthma and Type 2 Diabetes 10/30/2007
More...
|
Merck & Co., Inc. (MRK)'s (Jobs) Januvia Wins New Uses but Risks Outlined 10/18/2007
More...
|
ConjuChem Biotechnologies Inc. (CJB.TO) Reports Final Results of PC-DAC(TM) 10/18/2007
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes 10/18/2007
More...
|
Akesis Pharmaceuticals Files IND for Phase IIa Trial of AKP-020 to Treat Type 2 Diabetes 10/8/2007
More...
|
DiaMedica Inc. Announces Exciting Phase II Results for DM-71 in Type 2 Diabetes Trial 10/1/2007
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) (Jobs) Says SYMLIN Pen-Injector Devices Use Without Mealtime Insulin Not Approvable 10/1/2007
More...
|
Novartis International AG (NVS) Diabetes Drug Galvus Approved in Europe 9/28/2007
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos and GlaxoSmithKline (GSK)'s (Jobs) Avandia Heart Failure Risks Confirmed in Study 9/28/2007
More...
|
Novo Nordisk A/S (NVO)'s (Jobs) Levemir Has Mixed Results in Diabetes Study 9/21/2007
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 9/21/2007
More...
|
Takeda Pharmaceuticals North America, Inc. Release: ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes 9/19/2007
More...
|
DiaMedica Inc. Announces Positive Pre-Clinical Results for DM-83 9/18/2007
More...
|
Metabasis Therapeutics, Inc. (MBRX) Presents Promising Preclinical Results with Its Novel Glucagon Antagonist for the Treatment of Type 2 Diabetes 9/18/2007
More...
|
Test Measures Fat Around Organs 9/17/2007
More...
|
Phenomix Corporation Initiates Phase 2b Clinical Trial of PHX1149 for Type 2 Diabetes; Will Present PHX1149 Data at EASD 9/11/2007
More...
|
Genaera Corporation (GENR) Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436) 9/10/2007
More...
|
Hemoglobin A1c Can Predict Type 2 Diabetes in Women 9/7/2007
More...
|
Landmark Study Shows Blood Pressure Drugs Cut Death Rate in Type 2 Diabetes 9/7/2007
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes 9/4/2007
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB) Releases Preliminary Research Results For New Class of Diabetes Compounds 9/4/2007
More...
|
Karo Bio AB Provides Update of Internal Projects; KB5359 Discontinued; Further Clinical Trials Planned for KB2115 and KB3305 8/30/2007
More...
|
Sirtris Pharmaceuticals (SIRT) Initiates Phase 2a Clinical Trial in Patients with Type 2 Diabetes 8/21/2007
More...
|